Drugs / Z-213
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Filed | Japan (PMDA) | — | iron deficiency anemia | 2018-03-29 | “鉄欠乏性貧血治療剤「Z-213」につきましては、フェー ズⅢを終了し、平成30年３月に製造販売承認申請を実施いたしました。” zeria.co.jp ↗ |
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02170311 | Jun 2014 → Feb 2015 | iron deficiency anemia | Zeria Pharmaceutical | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02828319 | Jul 2016 → May 2017 | iron deficiency anemia | Zeria Pharmaceutical | Completed | No outcome recorded |
| Phase 3 | NCT02731534 | May 2016 → Mar 2017 | iron deficiency anemia | Zeria Pharmaceutical | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2018-03-29 | Zeria Pharmaceutical | Regulatory 鉄欠乏性貧血治療剤「Z-213」の製造販売承認申請のお知らせ zeria.co.jp ↗ |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2018-03-29 | Zeria Pharmaceutical | 鉄欠乏性貧血治療剤「Z-213」の製造販売承認申請のお知らせ zeria.co.jp ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Z-213 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02170311 ↗ |
| Route | Intravenous | “Z-213 will be administered by intravenous infusion.” NCT02170311 ↗ |